Your session is about to expire
← Back to Search
High-Intensity Exercise for Alzheimer's Disease (CYCLE-AD Trial)
CYCLE-AD Trial Summary
This trial is testing whether long-term, high intensity exercise can slow or delay the onset of Alzheimer's disease in people who are at risk for it.
CYCLE-AD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCYCLE-AD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CYCLE-AD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Indoor Cycling (IC)
- Group 2: Usual and Customary Care (UCC)
Frequently Asked Questions
Does this research endeavor include individuals who are over 35 years old?
"In accordance with the inclusion criteria, this clinical trial permits patients aged 65 to 80."
How can I become a participant in this medical experiment?
"This medical trial seeks to recruit 150 senior patients, aged 65-80 and suffering from Alzheimer's disease. Additionally, they must be healthy, lack cognitive impairment as measured by a screening exam, possess an APOE ε4 genotype, not exercise more than 3 times per week at moderate-vigorous intensity levels. Moreover all enrollees must be fluent in English for neurocognitive testing purposes; have access to Wi-Fi with which the Peloton system will transmit data (a common amenity across Cuyahoga county homes); receive medical clearance to partake in the program; meet Peloton safety requirements; commit to residing nearby"
Is this clinical trial still recruiting patients?
"Affirmative. The particulars available on clinicaltrials.gov indicates that this medical trial is actively recruiting now, with the initial post date of October 20th 2021 and latest amendment being made on October 31st 2022. A total of 150 patients are required to be enrolled from a single site."
How many individuals are participating in the investigation?
"Affirmative. Clinicaltrials.gov provides evidence that, since its posting on October 20th 2021, this clinical trial is actively searching for 150 patients at a solitary medical centre."
Share this study with friends
Copy Link
Messenger